LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 Dasatinib
3.33
uM
LJP6
 1
I02
 72
hr
 1657 1218 5505 0.2212 -0.1143
BT-20 Dasatinib
3.33
uM
LJP6
 2
I02
 72
hr
 1657 1080 5505 0.1962 -0.1501
BT-20 Dasatinib
3.33
uM
LJP6
 3
I02
 72
hr
 1657 1181 5505 0.2145 -0.1239
BT-20 Dovitinib
3.33
uM
LJP5
 1
E20
 72
hr
 1657 2735 5505 0.4968 0.2800
BT-20 Dovitinib
3.33
uM
LJP5
 2
E20
 72
hr
 1657 2353 5505 0.4274 0.1807
BT-20 Dovitinib
3.33
uM
LJP5
 3
E20
 72
hr
 1657 2337 5505 0.4245 0.1765
BT-20 Enzastaurin
3.33
uM
LJP5
 1
D14
 72
hr
 1657 6685 5505 1.2142 1.3065
BT-20 Enzastaurin
3.33
uM
LJP5
 2
D14
 72
hr
 1657 6099 5505 1.1078 1.1542
BT-20 Enzastaurin
3.33
uM
LJP5
 3
D14
 72
hr
 1657 6985 5505 1.2687 1.3844
BT-20 Erlotinib
3.33
uM
LJP5
 1
M20
 72
hr
 1657 4768 5505 0.8660 0.8083
BT-20 Erlotinib
3.33
uM
LJP5
 2
M20
 72
hr
 1657 4919 5505 0.8934 0.8475
BT-20 Erlotinib
3.33
uM
LJP5
 3
M20
 72
hr
 1657 4795 5505 0.8709 0.8153
BT-20 Foretinib
3.33
uM
LJP5
 1
H08
 72
hr
 1657 1559 5505 0.2832 -0.0257
BT-20 Foretinib
3.33
uM
LJP5
 2
H08
 72
hr
 1657 1672 5505 0.3037 0.0037
BT-20 Foretinib
3.33
uM
LJP5
 3
H08
 72
hr
 1657 1642 5505 0.2982 -0.0041
BT-20 R406
3.33
uM
LJP6
 1
C14
 72
hr
 1657 4918 5505 0.8933 0.8473
BT-20 R406
3.33
uM
LJP6
 2
C14
 72
hr
 1657 4844 5505 0.8798 0.8281
BT-20 R406
3.33
uM
LJP6
 3
C14
 72
hr
 1657 5137 5505 0.9330 0.9042
BT-20 Pictilisib
3.33
uM
LJP6
 1
D20
 72
hr
 1657 1675 5505 0.3042 0.0045
BT-20 Pictilisib
3.33
uM
LJP6
 2
D20
 72
hr
 1657 1815 5505 0.3297 0.0409
BT-20 Pictilisib
3.33
uM
LJP6
 3
D20
 72
hr
 1657 1750 5505 0.3179 0.0240
BT-20 Gefitinib
3.33
uM
LJP6
 1
N08
 72
hr
 1657 4837 5505 0.8786 0.8262
BT-20 Gefitinib
3.33
uM
LJP6
 2
N08
 72
hr
 1657 4975 5505 0.9036 0.8621
BT-20 Gefitinib
3.33
uM
LJP6
 3
N08
 72
hr
 1657 4760 5505 0.8646 0.8062
BT-20 Geldanamycin
3.33
uM
LJP5
 1
O02
 72
hr
 1657 1783 5505 0.3239 0.0326